These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 25203878)
1. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Parikh M; Chung M; Sheth S; McMacken M; Zahra T; Saunders JK; Ude-Welcome A; Dunn V; Ogedegbe G; Schmidt AM; Pachter HL Ann Surg; 2014 Oct; 260(4):617-22; discussion 622-4. PubMed ID: 25203878 [TBL] [Abstract][Full Text] [Related]
2. Three-year follow-up comparing metabolic surgery versus medical weight management in patients with type 2 diabetes and BMI 30-35. The role of sRAGE biomarker as predictor of satisfactory outcomes. Horwitz D; Saunders JK; Ude-Welcome A; Marie Schmidt A; Dunn V; Leon Pachter H; Parikh M Surg Obes Relat Dis; 2016 Aug; 12(7):1337-1341. PubMed ID: 27134202 [TBL] [Abstract][Full Text] [Related]
3. Short-Term Diabetes Remission Outcomes in Patients with BMI ≤ 30 kg/m Widjaja J; Pan H; Dolo PR; Yao L; Li C; Shao Y; Zhu X Obes Surg; 2020 Jan; 30(1):18-22. PubMed ID: 31428971 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional international study. Lee WJ; Hur KY; Lakadawala M; Kasama K; Wong SK; Lee YC J Gastrointest Surg; 2012 Jan; 16(1):45-51; discussion 51-2. PubMed ID: 22042564 [TBL] [Abstract][Full Text] [Related]
5. Effect of Bariatric Surgery vs Medical Treatment on Type 2 Diabetes in Patients With Body Mass Index Lower Than 35: Five-Year Outcomes. Hsu CC; Almulaifi A; Chen JC; Ser KH; Chen SC; Hsu KC; Lee YC; Lee WJ JAMA Surg; 2015 Dec; 150(12):1117-24. PubMed ID: 26374954 [TBL] [Abstract][Full Text] [Related]
6. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity. Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946 [TBL] [Abstract][Full Text] [Related]
7. Relationships between type 2 diabetes remission after gastric bypass and different weight loss metrics: arguments against excess weight loss in metabolic surgery. van de Laar AW; de Brauw LM; Meesters EW Surg Obes Relat Dis; 2016 Feb; 12(2):274-82. PubMed ID: 26476492 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes comparing metabolic surgery to no surgery in patients with type 2 diabetes and body mass index 30-35. Horwitz D; Padron C; Kelly T; Saunders JK; Ude-Welcome A; Schmidt AM; Parikh M Surg Obes Relat Dis; 2020 Apr; 16(4):503-508. PubMed ID: 32088110 [TBL] [Abstract][Full Text] [Related]
9. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9. Weng J J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564 [TBL] [Abstract][Full Text] [Related]
10. Predictors of long-term diabetes remission after metabolic surgery. Lee MH; Lee WJ; Chong K; Chen JC; Ser KH; Lee YC; Chen SC J Gastrointest Surg; 2015 Jun; 19(6):1015-21. PubMed ID: 25840670 [TBL] [Abstract][Full Text] [Related]
11. Laparoscopic sleeve gastrectomy versus single anastomosis (mini-) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of incretin effect. Lee WJ; Chong K; Lin YH; Wei JH; Chen SC Obes Surg; 2014 Sep; 24(9):1552-62. PubMed ID: 24965545 [TBL] [Abstract][Full Text] [Related]
12. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Ribaric G; Buchwald JN; McGlennon TW Obes Surg; 2014 Mar; 24(3):437-55. PubMed ID: 24374842 [TBL] [Abstract][Full Text] [Related]
14. Outcomes in weight loss, fasting blood glucose and glycosylated hemoglobin in a sample of 415 obese patients, included in the database of the European accreditation council for excellence centers for bariatric surgery with laparoscopic one anastomosis gastric bypass. Carbajo MA; Jiménez JM; Castro MJ; Ortiz-Solórzano J; Arango A Nutr Hosp; 2014 Nov; 30(5):1032-8. PubMed ID: 25365005 [TBL] [Abstract][Full Text] [Related]
15. Five-year effectiveness of bariatric surgery on disease remission, weight loss, and changes of metabolic parameters in obese patients with type 2 diabetes: A population-based propensity score-matched cohort study. Wu T; Wong SKH; Law BTT; Grieve E; Wu O; Tong DKH; Leung DKW; Lam CLK; Wong CKH Diabetes Metab Res Rev; 2020 Mar; 36(3):e3236. PubMed ID: 31912598 [TBL] [Abstract][Full Text] [Related]
17. Circulating soluble RAGE isoforms are attenuated in obese, impaired-glucose-tolerant individuals and are associated with the development of type 2 diabetes. Miranda ER; Somal VS; Mey JT; Blackburn BK; Wang E; Farabi S; Karstoft K; Fealy CE; Kashyap S; Kirwan JP; Quinn L; Solomon TPJ; Haus JM Am J Physiol Endocrinol Metab; 2017 Dec; 313(6):E631-E640. PubMed ID: 28811295 [TBL] [Abstract][Full Text] [Related]
18. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. Schauer PR; Kashyap SR; Wolski K; Brethauer SA; Kirwan JP; Pothier CE; Thomas S; Abood B; Nissen SE; Bhatt DL N Engl J Med; 2012 Apr; 366(17):1567-76. PubMed ID: 22449319 [TBL] [Abstract][Full Text] [Related]
19. Diabetes remission and insulin secretion after gastric bypass in patients with body mass index <35 kg/m2. Lee WJ; Chong K; Chen CY; Chen SC; Lee YC; Ser KH; Chuang LM Obes Surg; 2011 Jul; 21(7):889-95. PubMed ID: 21499957 [TBL] [Abstract][Full Text] [Related]
20. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Mingrone G; Panunzi S; De Gaetano A; Guidone C; Iaconelli A; Nanni G; Castagneto M; Bornstein S; Rubino F Lancet; 2015 Sep; 386(9997):964-73. PubMed ID: 26369473 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]